Pictet Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Pictet Asset Management's HALO Position: Q1 2026 in Review
Pictet Asset Management increased its Halozyme (HALO) stake by 7.3% in Q1 2026, buying an estimated $96.3K and bringing the position to 20,102 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1004.
Pictet Asset Management first reported a position in HALO in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.32M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Pictet Asset Management held 20,102 shares of Halozyme worth $1.3M as of Q1 2026.
- Pictet Asset Management bought 1,366 Halozyme shares in Q1 2026, an estimated $96.3K.
- Halozyme made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #1004 holding.
- Pictet Asset Management first reported a position in Halozyme in Q3 2023 and has held it in 11 quarters since.
- Pictet Asset Management's Halozyme position peaked at $1.32M in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.